The Motley Fool··Jonathan PoncianoAdaptive Biotech COO Sells $2.4M in Stock as Revenue Surges 55% YoY
Adaptive Biotechnologies COO Julie Rubinstein sold 179,703 shares for $2.37M via pre-arranged tax plan as company posts strong 55% revenue growth.
ADPTrevenue growthEBITDA